A Seven-Gene Signature Aggregates a Subgroup of Stage II Colon Cancers with Stage III

Prognostic and Predictive Markers in Stage II Colon Cancer: Is There a Role for Gene Expression Profiling?

(2011) Robin K. Kelley et al.   Clinical Colorectal Cancer

FKBP38-Bcl-2 interaction: a novel link to chemoresistance

(2011) Bo-Hwa Choi et al.   CURRENT OPINION IN PHARMACOLOGY

Implementing prognostic and predictive biomarkers in CRC clinical trials

(2011) Sandra Van Schaeybroeck et al.   Nature Reviews Clinical Oncology

Structure-Specific DNA Endonuclease Mus81/Eme1 Generates DNA Damage Caused by Chk1 Inactivation

(2011) Josep V. Forment et al.   PLoS One

The Proteomics of Colorectal Cancer: Identification of a Protein Signature Associated with Prognosis

(2011) Donna O'Dwyer et al.   PLoS One

Deletion of chromosome 4q predicts outcome in Stage II colon cancer patients

(2011) R. P. M. Brosens et al.   CELLULAR ONCOLOGY

Genomics and proteomics approaches to the study of cancer-stroma interactions

(2010) Flávia C Rodrigues-Lisoni et al.   BMC Medical Genomics

Nitric oxide and P-glycoprotein modulate the phagocytosis of colon cancer cells

(2010) Joanna Kopecka et al.   JOURNAL OF CELLULAR AND MOLECULAR MEDICINE

Defective Mismatch Repair As a Predictive Marker for Lack of Efficacy of Fluorouracil-Based Adjuvant Therapy in Colon Cancer

(2010) Daniel J. Sargent et al.   JOURNAL OF CLINICAL ONCOLOGY

Gene Expression Signature to Improve Prognosis Prediction of Stage II and III Colorectal Cancer

(2010) Ramon Salazar et al.   JOURNAL OF CLINICAL ONCOLOGY

Functional evidence for Eme1 as a marker of cisplatin resistance

(2009) Yoshitaka Tomoda et al.   INTERNATIONAL JOURNAL OF CANCER

Molecular Mechanisms of HIF-1α Modulation Induced by Oxygen Tension and BMP2 in Glioblastoma Derived Cells

(2009) Francesca Pistollato et al.   PLoS One

Amino acid regulation of TOR complex 1

(2008) Joseph Avruch et al.   AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM